Amarin Corp PLC (AMRN)
0.551
+0.03
(+4.97%)
USD |
NASDAQ |
Nov 22, 14:46
Amarin Total Liabilities (Quarterly): 219.24M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 219.24M |
June 30, 2024 | 247.98M |
March 31, 2024 | 244.08M |
December 31, 2023 | 279.59M |
September 30, 2023 | 285.88M |
June 30, 2023 | 290.89M |
March 31, 2023 | 275.40M |
December 31, 2022 | 290.85M |
September 30, 2022 | 320.48M |
June 30, 2022 | 393.19M |
March 31, 2022 | 332.60M |
December 31, 2021 | 400.97M |
September 30, 2021 | 393.31M |
June 30, 2021 | 399.67M |
March 31, 2021 | 355.64M |
December 31, 2020 | 338.52M |
September 30, 2020 | 352.95M |
June 30, 2020 | 312.11M |
March 31, 2020 | 339.89M |
December 31, 2019 | 273.95M |
September 30, 2019 | 271.04M |
June 30, 2019 | 240.84M |
March 31, 2019 | 231.37M |
December 31, 2018 | 233.38M |
September 30, 2018 | 263.11M |
Date | Value |
---|---|
June 30, 2018 | 250.82M |
March 31, 2018 | 232.37M |
December 31, 2017 | 226.70M |
September 30, 2017 | 212.72M |
June 30, 2017 | 208.95M |
March 31, 2017 | 203.97M |
December 31, 2016 | 176.06M |
September 30, 2016 | 178.73M |
June 30, 2016 | 312.05M |
March 31, 2016 | 308.85M |
December 31, 2015 | 300.78M |
September 30, 2015 | 293.51M |
June 30, 2015 | 286.52M |
March 31, 2015 | 277.16M |
December 31, 2014 | 259.56M |
September 30, 2014 | 254.61M |
June 30, 2014 | 255.82M |
March 31, 2014 | 277.80M |
December 31, 2013 | 286.33M |
September 30, 2013 | 311.54M |
June 30, 2013 | 309.00M |
March 31, 2013 | 331.42M |
December 31, 2012 | 314.85M |
September 30, 2012 | 254.96M |
June 30, 2012 | 265.86M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
219.24M
Minimum
Sep 2024
400.97M
Maximum
Dec 2021
317.36M
Average
316.29M
Median
Total Liabilities (Quarterly) Benchmarks
Trinity Biotech PLC | 123.79M |
Adaptimmune Therapeutics PLC | 237.45M |
Akari Therapeutics PLC | 9.428M |
NuCana PLC | 20.58M |
TC BioPharm (Holdings) PLC | 7.807M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 750.62M |
Shareholders Equity (Quarterly) | 531.38M |
Current Ratio | 3.226 |